Legal Representation
Attorney
Alyssa Worsham
USPTO Deadlines
Application History
43 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 29, 2021 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Nov 29, 2021 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Apr 6, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 5, 2021 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Apr 2, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 19, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 19, 2021 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Sep 25, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 23, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 23, 2020 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Sep 23, 2020 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Mar 31, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 27, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 27, 2020 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Mar 27, 2020 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Oct 5, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 3, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 3, 2019 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 3, 2019 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Apr 17, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 15, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 15, 2019 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 15, 2019 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 23, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 28, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 28, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 8, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 18, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 6, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 5, 2018 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Jul 5, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 27, 2018 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Jun 27, 2018 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Jun 27, 2018 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jun 8, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 7, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 7, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 15, 2017 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Dec 15, 2017 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
| Dec 15, 2017 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| Dec 11, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 11, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 8, 2017 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
diagnostic reagents for scientific or research use in the field of cancer including anal, biliary, neuroendocrine, endometrial, cervical, vulvar, small cell lung, mesothelioma, thyroid and salivary gland carcinoma cancers; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer including anal, biliary, neuroendocrine, endometrial, cervical, vulvar, small cell lung, mesothelioma, thyroid and salivary gland carcinoma cancers
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
diagnostic reagents for medical use in the field of cancer including anal, biliary, neuroendocrine, endometrial, cervical, vulvar, small cell lung, mesothelioma, thyroid and salivary gland carcinoma cancers; diagnostic reagent kits comprising primarily diagnostic reagents for medical use in the field of cancer including anal, biliary, neuroendocrine, endometrial, cervical, vulvar, small cell lung, mesothelioma, thyroid and salivary gland carcinoma cancers
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"IO"